All In Biotech

Free tool

FAERS Monitor: Cleocin Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050162 or its brand name (Cleocin Hydrochloride, Clindamycin Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

3,695

Serious

2,818

76% of reports

Hospitalization

1,395

Death reported

243

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea293
  • rash278
  • nausea258
  • off label use257
  • pain232
  • dyspnoea212
  • drug ineffective211
  • drug hypersensitivity197
  • headache181
  • pruritus179
  • fatigue168
  • arthralgia158
  • cough142
  • pyrexia131
  • vomiting131

Reports by year received

View as table
YearReports
200434
200580
200652
200743
200855
200950
201044
201161
201291
201340
201428
201551
2016123
201783
2018105
2019153
2020173
2021224
2022444
2023440
2024537
2025462
2026322

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,464 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug hypersensitivitySignal1975.85.1784
rashSignal2783.63.2538
coughSignal1422.92.5175
pruritusSignal1792.72.3186
diarrhoeaSignal2932.62.3292
arthralgiaSignal1582.21.9100
pyrexiaSignal1312.21.881
painSignal2322.21.9146
dyspnoeaSignal2122.11.9130
nausea2581.91.6105
off label use2571.71.572
headache1811.61.446
vomiting1311.61.328
fatigue1681.21.17
drug ineffective2110.90.82

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.